Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | November 01, 2023 09:06am

Gainers

  • Cellectis (NASDAQ:CLLS) stock rose 171.1% to $2.63 during Wednesday's pre-market session. The company's market cap stands at $146.1 million.
  • Monopar Therapeutics (NASDAQ:MNPR) stock rose 79.3% to $0.77. The market value of their outstanding shares is at $10.9 million.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) stock rose 31.38% to $0.11. The company's market cap stands at $4.6 million.
  • TG Therapeutics (NASDAQ:TGTX) shares moved upwards by 24.96% to $9.66. The company's market cap stands at $1.4 billion. As per the news, the Q3 earnings report came out today.
  • Aldeyra Therapeutics (NASDAQ:ALDX) shares moved upwards by 21.04% to $2.07. The company's market cap stands at $121.2 million.
  • Artelo Biosciences (NASDAQ:ARTL) shares increased by 14.97% to $1.42. The market value of their outstanding shares is at $4.0 million.

Losers

  • Iridex (NASDAQ:IRIX) shares fell 29.9% to $2.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $37.3 million.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) shares declined by 18.67% to $0.48. The market value of their outstanding shares is at $10.4 million.
  • Kintara Therapeutics (NASDAQ:KTRA) stock declined by 12.31% to $0.67. The company's market cap stands at $1.1 million.
  • G1 Therapeutics (NASDAQ:GTHX) stock decreased by 11.82% to $1.46. The company's market cap stands at $75.2 million. As per the news, the Q3 earnings report came out today.
  • Turnstone Biologics (NASDAQ:TSBX) stock decreased by 10.4% to $3.19. The company's market cap stands at $72.8 million.
  • Panbela Therapeutics (NASDAQ:PBLA) shares decreased by 8.21% to $0.75. The market value of their outstanding shares is at $2.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALDX ARTL CLLS GTHX IRIX KTRA MNPR PBLA TGTX TNXP TSBX ZVSA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist